Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of RhuDex granules in primary biliary cholangitis
2020-001961-34Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RhuDex in primary biliary cholangitis (PBC) (4 arms), sponsored by Dr. Falk Pharma GmbH. Started Sep 2020; status: completed.
02
Drugs
RhuDex
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2020-001961-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001961-34.